| Submit your comments on this article |
| Home Front: Politix |
| October surprise? |
| 2020-09-03 |
| [YNet] - The U.S. Centers for Disease Control and Prevention (CDC) has asked state public health officials to prepare to distribute a potential coronavirus vaccine to high-risk groups as soon as late October, documents published by the agency showed on Wednesday. The timing of a vaccine has taken on political importance as U.S. President Donald Trump seeks re-election in November, after committing billions of federal dollars to develop a vaccine to prevent COVID-19, which has killed more than 180,000 Americans. "For the purpose of initial planning, CDC provided states with certain planning assumptions as they work on state specific plans for vaccine distribution, including possibly having limited quantities of vaccines in October and November," a CDC spokeswoman told Reuters. |
| Posted by:g(r)omgoru |
| #10 ^ So are we. |
| Posted by: H-T-A 2020-09-03 14:35 |
| #9 ^A circumstance for which I'm tearfully grateful. |
| Posted by: g(r)omgoru 2020-09-03 12:47 |
| #8 Fortunately (g)rom, nutjob nervious nellies like you do not have a say in our politics. |
| Posted by: Theager Borgia1057 2020-09-03 12:32 |
| #7 Lefties will not trust any vaccine that Trump speaks highly of. A true fascist could take advantage of that sort of thing. |
| Posted by: rjschwarz 2020-09-03 10:14 |
| #6 Successfully impeached |
| Posted by: g(r)omgoru 2020-09-03 09:12 |
| #5 Trump will undoubtedly be impeached for SOMETHING next term anyways if the Democrats hold the House for any two year period. |
| Posted by: Vernal Hatrick 2020-09-03 09:04 |
| #4 I'm serious here, P2k. As far as election's are concerned - using non effective vaccine is a good way to be impeached. |
| Posted by: g(r)omgoru 2020-09-03 08:46 |
| #3 ...does it have to be any better than Biden's? |
| Posted by: Procopius2k 2020-09-03 08:29 |
| #2 #1 But does it produce immune memory? |
| Posted by: g(r)omgoru 2020-09-03 08:09 |
| #1 Novavax's experimental coronavirus vaccine triggered antibodies in 100% of trial participants, study reveals |
| Posted by: Skidmark 2020-09-03 07:38 |